Not a world-class policy?
A bit after posting on some early reaction to the U's new policy on conflicts of interest involving its medical school, I got this from U Professor Bill Gleason, who told me early on he didn't think the U's conflict-of-interest policy had any real bite.
He talks briefly to Pharmalot, which goes into more criticism of the policy and its controversial background.
They say the new policy lacks sanctions; there is no ban on consulting fees; there is no requirement for public disclosure of ties or holdings that may represent a conflict, and industry-funded continuing medical education is permitted, despite proposals to eliminate such financing.
Before you keep reading ...
MPR News is made by Members. Gifts from individuals fuel the programs that you and your neighbors rely on. Donate today to power news, analysis, and community conversations for all.